The bubble map of the first 20 KEGG metabolic pathways is shown in Figure 3c, suggesting that the MAPKs signaling pathway and TGF-β1/smads signaling pathway may be related to the SAA in the treatment of CKD. This evidence concerns the gene TGFB1 and chronic kidney disease.